During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

Find insight on Tencent, TikTok, Reach and more in the latest Market Talks covering Technology, Media and Telecom.

1 Day 603259 -0.99% DJIA 0.79% S&P 500 0.91% Health Care/Life Sciences 66.70% ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. | The deal includes facilities in ...

This underscores WuXi Biologics’ competitive edge on a global scale and the enduring trust from its clients, as evidenced by the significant number of new projects and the robust pipeline of ...

Legislation would have cut Chinese businesses off from US WuXi executives say the companies continue to sign new clients WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other ... ET Despite challenges in the CDMO industry, Samsung Biologics is "well positioned to kick-start a new ...